Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

SPHR913 anti-wrinkle serum - developed to lessen the effects of skin ageing

Sinclair Pharmaceuticals
SPHR913 anti-wrinkle serum is an innovative product researched and developed to lessen the effects of skin ageing. The key ingredient is telmesteine (N-carbetoxy-4-tiazolidin carboxylic acid).

Mechanism of action

It demonstrates an inhibitory effect against two metalloproteases which breaks down collagen and inhibits leukocyte elastase.

Full description

SPHR913 anti-wrinkle serum is an innovative product researched and developed to lessen the effects of skin ageing. The key ingredient is telmesteine (N-carbetoxy-4-tiazolidin carboxylic acid) .

Telmesteine has a number of key benefits, which makes it suitable as a powerful anti-wrinkle serum:

1) demonstrates an inhibitory effect against two metalloproteases, specifically MMP-2 and MMP-9, which breaks down collagen. These effects were demonstrated in vitro and were evident even at very low levels of telmesteine (from 7mM to 10mM) . Collagen degradation is one of the principal reasons why wrinkles develop.

2) inhibits leukocyte elastase. In vitro results showed that telmesteine inhibited leukocyte elastase, again at a very low level (100uM) . Elastin degradation is another factor that leads to wrinkle onset.

3) has an anti-hyaluronidase effect. The main function of Hyaluraric Acid is to lubricate knee, elbow, finger and toe joints. Another role it plays is to hold water within the matrix of collagen and elastin. Hyaluronic acid also smoothes out the skin's surface and can make the skin less rough. Because telmesteine inhibits the rapid degradation of hyaluronic acid, it also works to prolong the life of cosmetic products that contain this popular ingredient.

4) has a scavenging action on free radicals, as well as an "anti-ageing" effect. Oxidative damage is one of the major causes of skin wrinkles. Tests of glutathion-peroxidase activity and microsomial oxidation clearly indicate the "free radical scavenger" action of telmesteine . Furthermore, it also demonstrated a protective function against the oxidating agents responsible for epithelial damage .

5) contains a sulphur atom in its structure, which helps to support normal keratin formation. Keratin cells are found in the epidermis and play a major role in maintaining skin's strength and elasticity. Similar to the degradation of collagen and elastic, keratin breakdown leads to the onset of skin wrinkles.

6) is widely used in the field of respiratory tract disorders. It has consequently undergone numerous clinical studies and has a long track record of efficacy and, equally important, safety. Furthermore, SPHR913 has several studies proving its safety .

The formation of wrinkles is a natural, physiological process that accompanies the ageing process. Over time, the skin naturally becomes thinner, less elastic and more fragile. Oil production is decreased and fewer fat cells are produced. These changes coupled with a gradual breakdown of skin's connective tissue results in skin losing its strength and flexibility. Skin degradation is controlled by many enzymes, and their regulation is fundamental in order to control wrinkles.

When wrinkles appear, many people turn to the cosmetic counter looking for solutions. The market today offers many products, which are in most cases clinically proven.

Development status

Registered

Patent information

PCT/EP2004/011228-WO 2005/037275 A1

 

Type of business relationship sought

This product is available for in-licensing on an exclusive basis around the world.

Licensing contact

Javier Boza
Global Business Development Director
Request more information

More information

For more information about the product please visit website.

Company details

Sinclair Pharmaceuticals
Sinclair Pharma plc, a rapidly growing UK based pharmaceutical company is seeking distributors around the world.

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Biomarkers for sepsis and infectious diseases
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us